Hims & Hers Health Inc is a household & personal products business based in the US. HIMS shares (HIMS) are listed on the NYSE and all prices are listed in US Dollars. HIMS employs 181 staff and has a trailing 12-month revenue of around USD$195.8 million.
Promoted for
Free Trades
Promoted for
Beginners
Promoted for
US Stocks
Promoted for
Savvy Investors
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
| Latest market close | $8.36 |
|---|---|
| 52-week range | $6.71 - $25.40 |
| 50-day moving average | $8.11 |
| 200-day moving average | $9.99 |
| Wall St. target price | $11.75 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.49 |
Note: The dollar amounts in the table below are in Canadian dollars.
Historical closes compared with the close of $8.36 from 2021-10-15
| 1 week (2021-10-07) | N/A |
|---|---|
| 1 month (2021-09-17) | -4.24% |
| 3 months (2021-07-16) | -8.43% |
| 6 months (2021-04-16) | -32.03% |
| 1 year (2020-10-16) | -19.69% |
|---|---|
| 2 years (2019-10-18) | -15.13% |
| 3 years (2018-10-14) | N/A |
| 5 years (2016-10-14) | N/A |
| Revenue TTM | $195.8 million |
|---|---|
| Gross profit TTM | $109.5 million |
| Return on assets TTM | -20.39% |
| Return on equity TTM | -37.49% |
| Profit margin | -36.6% |
| Book value | $1.52 |
| Market capitalisation | $1.7 billion |
TTM: trailing 12 months
There are currently 6.4 million HIMS shares held short by investors – that's known as HIMS's "short interest". This figure is 15.3% up from 5.6 million last month.
There are a few different ways that this level of interest in shorting HIMS shares can be evaluated.
HIMS's "short interest ratio" (SIR) is the quantity of HIMS shares currently shorted divided by the average quantity of HIMS shares traded daily (recently around 2.5 million). HIMS's SIR currently stands at 2.54. In other words for every 100,000 HIMS shares traded daily on the market, roughly 2540 shares are currently held short.
However HIMS's short interest can also be evaluated against the total number of HIMS shares, or, against the total number of tradable HIMS shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HIMS's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 HIMS shares in existence, roughly 30 shares are currently held short) or 0.0638% of the tradable shares (for every 100,000 tradable HIMS shares, roughly 64 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against HIMS.
We're not expecting HIMS to pay a dividend over the next 12 months.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc.
Stock trading doesn’t have to be expensive. Using Finder’s proprietary algorithm, we’ve identified the best cheap Canadian and US stocks to buy now.
Read more…
Cue Health—developer of a COVID-19 self-testing kit with conditional approval in the US, Canada, European Union and India—has gone public. Here’s how to buy in.
Read more…
Steps to owning and managing ARBK stock, with 24-hour and historical pricing before you buy.
Read more…Steps to owning and managing ITUB, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing BSX stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing WM stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing MIN stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing LUC stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing GSV stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing FCU stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing AII stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing USA stock, with 24-hour and historical pricing before you buy.
